Morisaki N, Kobayashi H, Iwasaki S, Furihata K, Dabbs E R, Yazawa K, Mikami Y
Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.
J Antibiot (Tokyo). 1995 Nov;48(11):1299-303. doi: 10.7164/antibiotics.48.1299.
Rifampicin (I) was converted into two inactivated products RIP-Ma and RIP-Mb by Mycobacterium smegmatis DSM43756. MS, NMR and chromatographic analysis showed the compounds to be 3-formyl-23-[O-(alpha-D-ribofuranosyl)]rifamycin SV (6) and 23-[O-(alpha-D-ribofuranosyl)]rifampicin (7), respectively.
利福平(I)被耻垢分枝杆菌DSM43756转化为两种失活产物RIP-Ma和RIP-Mb。质谱、核磁共振和色谱分析表明,这两种化合物分别为3-甲酰基-23-[O-(α-D-呋喃核糖基)]利福霉素SV(6)和23-[O-(α-D-呋喃核糖基)]利福平(7)。